Indometacin Aspen Pharma

Indometacin, the active ingredient in Indometacin Aspen Pharma, is a nonsteroidal anti-inflammatory drug presented as a rectal suppository for rectal use. It is employed to relieve inflammation and pain associated with several rheumatic and musculoskeletal conditions. GNH USA supplies Indometacin Aspen Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indometacin is used to manage inflammatory and painful conditions within the musculoskeletal and rheumatologic disease families.

- Rheumatoid arthritis: reduces joint inflammation and pain. - Osteoarthritis: alleviates chronic joint discomfort. - Ankylosing spondylitis: diminishes spinal inflammation. - Acute gout attacks: provides rapid relief of gouty joint pain. - Post‑operative pain: helps control postoperative inflammatory pain.

Indometacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastro‑intestinal upset: nausea, abdominal pain, dyspepsia. - Diarrhea or constipation. - Headache. - Dizziness. - Skin rash. - Elevated liver enzymes.

Serious or Rare Side Effects: - Gastro‑intestinal ulceration or bleeding. - Acute renal impairment or failure. - Severe hepatic injury. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylactic reactions. - Cardiovascular events such as myocardial infarction or stroke.

When prescribing Indometacin, clinicians should consider several safety measures.

- Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Monitor renal function: check serum creatinine and urine output regularly. - Evaluate hepatic status: perform liver function tests before and during therapy. - Use the lowest effective dose: limit exposure to reduce adverse events. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Indometacin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleeding. - Lithium: elevated lithium serum concentrations.

Moderate Interactions (Monitor Closely): - Methotrexate: possible increased toxicity. - Cyclosporine: enhanced nephrotoxic potential. - Corticosteroids: additive risk of gastrointestinal ulceration.